XML 29 R19.htm IDEA: XBRL DOCUMENT v3.24.3
Insider Trading Arrangements
 3 Months Ended 9 Months Ended
Sep. 30, 2024
shares
Sep. 30, 2024
shares
Trading Arrangements, by Individual    
Material Terms of Trading Arrangement  
During the quarter ended September 30, 2024, our directors and officers (as defined in Rule 16a-1(f) under the Exchange Act) adopted or terminated the contracts, instructions, or written plans for the purchase or sale of our securities set forth in the table below:
Name and PositionActionAdoption/Termination Date
Type of Trading Arrangement: Rule 10b5-1(1)
Total Shares of Common Stock to be SoldExpiration Date
Martha Morrell,
Chief Medical Officer
AdoptionSeptember 17, 2024X
92,232 (2)
June 30, 2025
_________________
(1)Contract, instruction or written plan intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) under the Exchange Act.
(2)Including the exercise and sale of up to 92,232 shares of the Company’s common stock subject to stock options.
Non-Rule 10b5-1 Arrangement Adopted false  
Rule 10b5-1 Arrangement Terminated false  
Non-Rule 10b5-1 Arrangement Terminated false  
Martha Morrell [Member]    
Trading Arrangements, by Individual    
Name Martha Morrell  
Title Chief Medical Officer  
Rule 10b5-1 Arrangement Adopted true  
Adoption Date September 17, 2024  
Expiration Date June 30, 2025  
Arrangement Duration 286 days  
Aggregate Available 92,232 92,232